You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Maria Sjöberg

Chief Executive Officer at Karo Pharma AB
Overview
Relationships
In The News
Paths
Career History

Maria Sjöberg

Chief Executive Officer at Karo Pharma AB

Overview

Age
54 (Born 1964)
Notable Companies
Karo Pharma AB
Number of Relationships
This person is connected to 188 people.

Relationships See Details


Executive Chairman at Karo Pharma AB

Director at Karolinska Institutet

Chief Financial Officer & Executive Vice President at Karo Pharma AB

Professor at Karolinska Institutet

Chairman & Chief Executive Officer at CIMON AB

Member, Nominating Committee at Karo Pharma AB

Member, Nominating Committee at Karo Pharma AB

Partner at Partners för Utvecklingsinvesteringar inom Life Sciences AB

Chief Executive Officer & Director at Emerentia Gruppen AB

Chairman at Ferrosan Medical Devices
See 178 more listings with RelSci Professional.

In The News See More

Business Wire
April 29, 2015
Business Wire
February 13, 2015
Business Wire
February 4, 2015
PR Newswire
July 9, 2013

Paths to Maria Sjöberg

Maria Sjöberg
You
Connections via Relationship Science
Maria Sjöberg
Sync your contacts to see how you can connect with Maria Sjöberg.

Career History

Chief Executive Officer
2011 - Current
Karo Pharma AB is a development company, which engages in research & development and distribution of innovative drugs for key medical needs. It involves in development, acquisition as sale of pharmaceutical products. It also provides preclinical development services in the fields of neuropsychiatry, inflammation, autoimmune diseases and cancer. The company was founded in 1987 and is headquartered in Stockholm, Sweden.
Director-Production, Head-Research & Development
Prior - 2012
SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer.SentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises).SentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D.SentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn.
Group Leader
Prior
Karolinska Institutet is a medical university in Solna within the Stockholm urban area, Sweden, and one of Europe's largest and most prestigious medical universities. It was founded in 1810 on Kungsholmen on the west side of Stockholm; the main campus was relocated decades later to Solna, just outside Stockholm. A second campus was established more recently in Flemingsberg, Huddinge, south of Stockholm.
Senior Scientist
Prior
AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom.

Other Affiliations

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.